In our last two episodes we discussed the impact of U.S. policy shifts on global FDA-regulated products supply chain and shared industry perspectives on global supply chain disruptions. On today’s episode, we unpack the sweeping tax reforms introduced by the One Big Beautiful Bill Act signed into law on July 4, 2025. With major changes to R&D expensing, international tax regimes, and incentives for domestic manufacturing, the bill is poised to reshape the global pharmaceutical supply chain. We explore how these provisions affect multinational pharma companies’ supply chain strategies.
Winston Kirton – wkirton@bakerlaw.com
Brian Davis – bdavis@bakerlaw.com
Popular Podcasts
Las Culturistas with Matt Rogers and Bowen Yang
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.